The Phase 3 TRIUMPH program is generating the data the FDA requires, and if the trials read out as expected, the retatrutide FDA approval story that began with a striking Phase 2 paper in 2023 will likely have its next chapter written in 2026
(2004, September)
What bodybuilders actually report Across bodybuilding forums including EliteFitness, UK-Muscle, and various peptide communities, several consistent themes emerge from real-world retatrutide use
Mounjaro By combining GLP-1 and GIP, this once-a-week injection controls appetite and blood sugar, all while reducing side effects
Mild side effects may include nausea, stomach upset, or headaches in some individuals
Reduccin aproximada del 16% en mortalidad por cualquier causa frente a dulaglutida